Varenicline brand?

What is Varenicline and its brand variants?

Varenicline, also known as Champix, is a prescription medication used to help people quit smoking. It works by reducing the pleasurable effects of smoking and the cravings that come with it. Varenicline is available under different brand names, including Chantix (a brand licensed by Pfizer for the US market) and Varenicline Hydrochloride (a generic form available in various countries).

Who makes Varenicline and its derivatives?

Varenicline was developed by Pfizer and is now marketed and distributed by various pharmaceutical companies worldwide. The drug's intellectual property is covered by a comprehensive patent portfolio, with different patents expiring at various dates, including the original patent that expired in 2020 [1] DrugPatentWatch.com.

How long does patent protection last for Varenicline?

According to various sources, including DrugPatentWatch.com [2], patent protection for Varenicline has expired in many countries, allowing generic versions of the medication to enter the market. However, patent filings and regulatory reviews can extend the exclusivity period, and specific dates may vary depending on the country and region.

What side effects and patient concerns are associated with Varenicline?

As with any medication, Varenicline can have side effects, including nausea, headache, insomnia, and increased liver enzyme levels [3]. Patients should consult their doctor before taking Varenicline, especially if they have a history of psychiatric disorders or are taking other medications.

Can biosimilars or generic versions of Varenicline enter the market before the patent expires?

In the United States, the FDA has approved several generic versions of Varenicline, which are marketed by different companies. These generic versions are often biosimilars, meaning they mimic the active ingredient in the original medication [4]. While generic entry can happen before patent expiration, regulatory review and patent litigation can delay or prevent market entry.

Sources:

[1] https://drugpatentwatch.com/drug/Chantix
[2] https://drugpatentwatch.com/drug/Chantix#patents
[3] https://www.medicinenet.com/chantix/drug-side-effects
[4] https://www.fda.gov/news-events/meeting-materials/food-and-drug-administration-advisory-committee/meeting-materials/pharmaceutical-biological-review-board/2020/2020-06-25-PBAR%20meeting-materials-presentation-14.pdf